Pembrolizumab,Gemcitabine,Cisplatin
Merck
['gemcitabine', 'cisplatin', 'bcsm', 'pembro']
first-line pembrolizumab plus gemcitabine/cisplatin may improve overall survival in advanced biliary tract cancer #hpbcsm #biliarytractcancer #oncology #immunotherapy #aacr23 
News and views from the world of clinical oncology and hematology